BioSpace News Archive

Policy

Testimony: Holmes Offered to Buy Out Investor Seeking “Straight Answers”

Houston-based money manager Alan Eisenman testified in the ongoing Elizabeth Holmes fraud trial that he sought “straight answers” about the company’s work for several years.

November 12, 2021
·
3 min read
·
Alex Keown
Drug Development

Adaptimmune Confident T-Cell Therapy Will Hit Efficacy Endpoint

Adaptimmune said that afamitresgene autoleucel (afami-cel) had a significantly positive effect on patients diagnosed with myxoid/round cell liposarcoma (MRCLS) and advanced synovial sarcoma.

November 12, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Biogen Says Aduhelm Significantly Lowers Another Top Alzheimer’s Biomarker

Boston-based Biogen shared data from two Phase III studies at the Clinical Trials on Alzheimer’s Disease conference that showed the latest efficacy data of Aduhelm (aducanumab).

November 12, 2021
·
3 min read
·
Alex Keown
Job Trends

Lundbeck Cuts 300 Employees; List Biotherapeutics Scales Up in Indiana

It’s been a week of gained and lost opportunities after two large biopharmaceutical firms announced changes to their staff rosters.

November 12, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

Moderna: Vaccine mRNA Sequence Was Selected Without NIH Input

Moderna responded to claims that the government should be co-patent owners of the mRNA vaccine developed by the company and said its mRNA sequence was exclusively selected by Moderna scientists.

November 12, 2021
·
3 min read
·
Alex Keown
Business

Non-Profit Period for AstraZeneca COVID Vaccine Coming to an End

The total revenue for the quarter was $9.74 billion, a leap of 47%. The COVID-19 vaccine, Vaxzevria, only contributed 1% to the company’s profit.

November 12, 2021
·
4 min read
·
Mark Terry
BioCapital

Clinical Catch-Up: November 8-12

It was another busy week for clinical trial news. Here’s a look.

November 12, 2021
·
12 min read
·
Mark Terry
Business

Biden Nominates Robert Califf to Lead FDA at Critical Juncture

President Joe Biden has nominated former U.S. Food and Drug Administration Commissioner Robert Califf to reprise his role at the agency’s helm.

November 12, 2021
·
2 min read
·
Heather McKenzie
Pharm Country

J&J Splitting Pharma and Consumer Businesses to Advance Efforts in Both

Johnson & Johnson is planning to break off its consumer products business from its pharmaceutical and medical device businesses. They will become two publicly traded companies.

November 12, 2021
·
3 min read
·
Mark Terry
Business

Mirion Technologies Announces Results for the Fiscal Quarter Ended September 30, 2021

Mirion Technologies, Inc. today announced results for the quarter ended September 30, 2021.

November 12, 2021
·
20 min read